The pharmaceutical company Eli Lilly will cap out-of-pocket insulin costs at $35 per month for all patients, according to NBC News. The Inflation Reduction Act previously imposed a $35 cap on insulin for Medicare beneficiaries, but Eli Lilly's new policy will automatically extend the lower price to privately insured patients as well. Uninsured patients are also eligible for the cap if they enroll in the drug company's copay assistance program.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
